Jifang Zhou

3.4k total citations
83 papers, 775 citations indexed

About

Jifang Zhou is a scholar working on Epidemiology, Hematology and Oncology. According to data from OpenAlex, Jifang Zhou has authored 83 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hematology and 12 papers in Oncology. Recurrent topics in Jifang Zhou's work include Ferroelectric and Piezoelectric Materials (12 papers), Microwave Dielectric Ceramics Synthesis (11 papers) and Acoustic Wave Resonator Technologies (7 papers). Jifang Zhou is often cited by papers focused on Ferroelectric and Piezoelectric Materials (12 papers), Microwave Dielectric Ceramics Synthesis (11 papers) and Acoustic Wave Resonator Technologies (7 papers). Jifang Zhou collaborates with scholars based in China, United States and Italy. Jifang Zhou's co-authors include Gregory S. Calip, Charlesnika T. Evans, Katie J. Suda, Ting Zhang, Yuhong Liu, Susan Rowan, Jessina C. McGregor, Tao Chen, Jianwei Zhang and Ronald C. Hershow and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jifang Zhou

74 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jifang Zhou China 14 181 164 118 118 108 83 775
Yu Jin Kim South Korea 20 70 0.4× 89 0.5× 133 1.1× 4 0.0× 84 0.8× 114 1.3k
Xingyue Huang United States 20 94 0.5× 5 0.0× 113 1.0× 16 0.1× 236 2.2× 68 1.0k
Ritesh Kumar India 21 14 0.1× 22 0.1× 560 4.7× 72 0.6× 23 0.2× 154 1.6k
Ichiro Takeuchi Japan 20 36 0.2× 23 0.1× 144 1.2× 6 0.1× 271 2.5× 167 1.6k
Lukshe Kanagaratnam France 19 18 0.1× 51 0.3× 81 0.7× 9 0.1× 18 0.2× 75 902
David Cohen United States 16 7 0.0× 28 0.2× 95 0.8× 25 0.2× 54 0.5× 34 953
LeAnn B. Norris United States 15 51 0.3× 22 0.1× 122 1.0× 3 0.0× 18 0.2× 38 790
Hyeon Seok Hwang South Korea 22 82 0.5× 164 1.0× 141 1.2× 1 0.0× 64 0.6× 123 1.5k
Won Jun Kim South Korea 7 75 0.4× 39 0.2× 65 0.6× 14 0.1× 6 0.1× 20 563

Countries citing papers authored by Jifang Zhou

Since Specialization
Citations

This map shows the geographic impact of Jifang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifang Zhou more than expected).

Fields of papers citing papers by Jifang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jifang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifang Zhou. The network helps show where Jifang Zhou may publish in the future.

Co-authorship network of co-authors of Jifang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jifang Zhou. A scholar is included among the top collaborators of Jifang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jifang Zhou. Jifang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Noguchi, Yoshihiro, Jifang Zhou, Ryo Kobayashi, & Tomoaki Yoshimura. (2025). A Consideration of Exploratory Approaches to Comedications Associated With Immune‐Related Adverse Events during Immune Checkpoint Inhibitor Therapy. Clinical Pharmacology & Therapeutics. 119(2). 306–307.
5.
6.
Xiao, Yue, et al.. (2023). Development and validation of a patient satisfaction survey for pharmaceutical service at primary care settings. International Journal for Quality in Health Care. 35(3). 2 indexed citations
7.
Zhou, Jifang, Karen Sweiss, Edith A. Nutescu, et al.. (2021). Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncology Practice. 17(3). e294–e312. 9 indexed citations
8.
Yan, Rui, Zhou Wang, Xiangyi Cui, et al.. (2021). PandaX-4T cryogenic distillation system for removing krypton from xenon. Review of Scientific Instruments. 92(12). 123303–123303. 5 indexed citations
9.
Zhou, Jifang, Gregory S. Calip, Edith A. Nutescu, et al.. (2021). Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis. SHILAP Revista de lepidopterología. 2(1). 94–98. 2 indexed citations
11.
Zhou, Jifang, Edith A. Nutescu, Jin Han, & Gregory S. Calip. (2020). Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis. Journal of Cancer Survivorship. 14(3). 294–304. 10 indexed citations
12.
Strand, Vibeke, et al.. (2019). Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data. Current Medical Research and Opinion. 36(1). 161–168. 8 indexed citations
13.
Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2019). Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six‐year population‐based cohort analysis. British Journal of Haematology. 185(1). 116–127. 12 indexed citations
14.
Taleb, Abdoh, Jifang Zhou, Jie Yang, et al.. (2019). Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria. Biomedicine & Pharmacotherapy. 111. 1478–1498. 50 indexed citations
15.
Lee, In-Young, Sruthi Adimadhyam, Edith A. Nutescu, et al.. (2019). Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High‐Grade Gliomas: A Nested Case‐Control Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(9). 921–928. 11 indexed citations
16.
Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2018). Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6‐year population‐based cohort study. British Journal of Haematology. 182(2). 259–270. 13 indexed citations
17.
Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2018). Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts. Blood. 132(Supplement 1). 4817–4817. 2 indexed citations
18.
Zhou, Jifang, Gregory S. Calip, Jin Han, & Edith A. Nutescu. (2017). Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study. Blood. 130. 2139–2139. 1 indexed citations
19.
Han, Jin, Jifang Zhou, Santosh L. Saraf, Victor R. Gordeuk, & Gregory S. Calip. (2017). Characterization of opioid use in sickle cell disease. Pharmacoepidemiology and Drug Safety. 27(5). 479–486. 41 indexed citations
20.
Zhou, Jifang, et al.. (2017). The emotional journey among caregivers of patients with leukemia: The caregivers’ perspective using social media listening.. Journal of Clinical Oncology. 35(15_suppl). e18568–e18568. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026